Deliver Your News to the World

SmallCapNewsRelease:(OTC: HBRM) Focused On Developing Alternatives For Treatment And Pain


WEBWIRE

JERICHO, NY--(SmallCapNewsRelease)--May 28th, 2010, Herborium Group, Inc. (OTC: HBRM) announced today that they are focusing on the over the counter alternative medicine market.

With an estimated 1 trillion dollar global market for alternative and complimentary medicines, Herbonium uses clinical validation and FDA Guidance to establish its differential advantage.

Herbonium’s pipeline of therapeutics are aimed at women’s and men’s health, including both dermatology and benign prostate hyperplasia (BPH), which affects almost half of the male population over 50 years old.

To view the entire press release, please visit http://finance.yahoo.com/news/Herborium-Group-Inc-Focuses-iw-2548169042.html?x=0&.v=1

For more information on Herbonium Group, visit www.smallcapsociety.com/hbrm.php

SmallCapNewsRelease gainers are Tower Semiconductor Ltd (NASDAQ: TSEMG) CKX Inc (NASDAQ: CKXE) Broadway Financial Corp (NASDAQ: BYFC) Roberts Realty Investors (AMEX: RPI) Waccamaw Bankshares (NASDAQ: WBNK) Jackson Hewitt Tax Service (NYSE: JTX) First Community Bank Corp (NASDAQ: FCFL) Synthetic Fixed (NYSE: GJW)

SmallCapNewsRelease decliners are DJSP Enterprises (NASDAQ: DJSPW) Blue Coat Systems (NASDAQ: BCSI) Good Times Restaurants (NASDAQ: GTIM) The Allied Defense Group (AMEX: ADG) Ameritrans Capital Corp (NASDAQ: AMTCP) Universal Holdings (NYSE: UVV) Beasley Broadcast Group (NASDAQ: BBGI) CFS Bancorp (NASDAQ: CITZ)

Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor’s reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. A third party has hired and paid Small Cap News Release twelve hundred and ninety five dollars for the publication and circulation of this news release. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. We have no ownership of equity, no representation, do no trading of any kind and send no faxes or emails.



WebWireID117755




 
 HBRM
 Nutraceuticals
 Therapeutics
 Medicine
 Penny Stock


This news content may be integrated into any legitimate news gathering and publishing effort. Linking is permitted.

News Release Distribution and Press Release Distribution Services Provided by WebWire.